|
The Stanley J. Korsmeyer Award
The Stanley J. Korsmeyer Award is named in honor of Dr. Korsmeyer, who was the first recipient of the Award in 1998 and who passed away in March 2005. The annual Award recognizes the outstanding achievements of an ASCI member in advancing knowledge in a specific field and in mentoring future generations of life-science researchers. The Award recipient receives an unrestricted $10,000 grant from the Society and presents the Award Lecture at the Society's annual meeting.
Recipient of the 2008 Award
Gerald I. Shulman, M.D., Ph.D., is the recipient of the 2008 Stanley J. Korsmeyer Award for his contributions to furthering our understanding of the mechanisms underlying the pathogenesis of type 2 diabetes.
Prior Award recipients
| 2007 | D. Gary Gilliland |
| for his contributions to the understanding of the genetic basis of human hematological malignancies. More information | |
| 2006 | Shaun R. Coughlin |
| For his outstanding contributions in the field of signal transduction via thrombin receptors. More information | |
| 2005 | Francis Collins |
| For his pioneering efforts in the development of the entire field of human genome research. More information | |
| 2004 | David Ginsburg |
| For his contributions to the understanding of the molecular basis of physiologic and pathologic thrombosis and hemostasis. More information | |
| 2003 | Craig B. Thompson |
| For his discovery of the critical role costimulatory receptors play in regulating immune responses. More information | |
| 2002 | Ronald DePinho |
| For fundamental discoveries in cancer research, aging, and chronic degenerative disease. More information | |
| 2001 | Laurie Glimcher |
| For seminal contributions to our understanding of the transcriptional regulation of lymphocyte subset differentiation. | |
| 2000 | Christine Seidman |
| For employing molecular genetic approaches in defining the etiology of inherited human disorders and genetic engineering to produce murine models of human disease, with particular emphasis on heart disease. | |
| Finalists: Jonathan S. Stamler, for elucidating the fundamental role of redox systems in the control of complex physiological responses, using NO-based modification of proteins-in particular S-nitrosylation. Mark Keating, for focusing on the molecular genetics of cardiovascular disease, particularly cardiac arrhythmias, cardiomyopathy and obstructive vascular disease. | |
| 1999 | Richard D. Klausner |
| For the discovery of key mechanisms that regulate metal metabolism and intracellular trafficking. More information | |
| Finalists: Michael J. Welsh, for discoveries regarding the molecular and cellular pathogenesis of cystic fibrosis. David Clapham, for discoveries regarding the regulation of membrane ion channels, and the physiologic consequences of intracellular calcium signals. | |
| 1998 | Stanley J. Korsmeyer |
| For the identification of key genetic mechanisms that govern cell death and survival. More information | |
| Finalists: Peter Agre, for discoveries regarding the roles of water channels in cell membranes. Arthur Weiss, for discoveries of key signalling pathways in T lymphocytes. |